The ease of accessibility to genotype information through peripheral blood or saliva sampling and advances in molecular techniques has increased the feasibility of DNA collection and genotyping not only in large-scale clinical trials; it works for individuals searching for ways to manage their own chronic pain conditions, as well.
If personalized medicine is widely adopted and used, then medical trials will become more efficient because researchers will know much more about exactly what they’re searching for and also for whom they’re searching.
This will lower the societal and individual costs of adverse drug side effects and the prescription of drugs that have been proven ineffective in certain genotypes.
Results can be presented showing which drugs the body is capable of breaking down normally versus the drugs that may be a problem, either because the drug is metabolized too quickly or too slowly.
The best part is that this test only needs to be done once, yet it can provide so much valuable information, including a summary of an individual’s genetic polymorphisms that could help both in an emergency situation and also on ongoing pain management basis.